psychedelics Archives

Connecticut Expands Its Psychedelic Therapy Pilot Program Ahead of Possible Federal Approval

Gov. Ned Lamont has signed Senate Bill 191, a measure that expands the state’s existing psychedelic therapy pilot program.

Ketamine’s Depression Effects May Be More Complicated Than We Thought

A new commentary in The American Journal of Psychiatry argues that ketamine’s antidepressant effects may involve a wider set of brain systems.

Navy Veteran Creates App to Track Mental Health Changes From Psychedelics

The app, called INVI Mindhealth, was created by former Navy SEAL Jonathan Wilson after he sought psychedelic treatment outside the US.

Insurance Trade Publication Urges Insurers to Prepare for Psychedelic Medicine

Insurance Business, a trade publication for the insurance sector, is now telling insurers to pay closer attention to psychedelic medicine. In a recent column, neuropsychopharmacologist Dr. Rayyan Zafar argued that psychedelic therapies are moving from fringe science into clinical, commercial, and regulatory reality. His larger point was not subtle. Insurers should not wait for the […]

Michigan Rep. Jack Bergman Says Psychedelic Treatment Research Has Reached a New Moment

Rep. Jack Bergman, a Michigan Republican and one of Congress’s leading voices on psychedelics, says the window for action has opened wider.

Ohio Lawmakers Consider Ibogaine Research As Veterans Push For New PTSD And Addiction Options

The discussion, led through Ohio’s Ibogaine Treatment Study Committee, reflects a broader shift in psychedelic policy.

Lawmakers Push FDA to Speed Up Psychedelic Therapy Reviews

They asked the agency to advance evaluations of rapid acting therapeutics for PTSD, traumatic brain injury and related conditions.

From LSD Hearings to Trump’s Psychedelic Order: A 60 Year Timeline of Washington’s Evolving View of Psychedelics

Here's a timeline of Washington's evolving view on psychedelics. From LSD research to the War on Drugs to today’s push for mental health.

How Media Outlets Are Reacting to Trump’s Psychedelics Executive Order

Trump’s executive order on psychedelics pushed a once fringe issue into the center of health policy. The coverage shows a clear pattern.

Why the Trump Psychedelics Executive Order Makes This the Most Important Moment to Join the Healing Health Alliance

Something happened in Washington last week that changes the economics of running a ketamine or psychedelic-adjacent clinic in America. President Trump’s April 18, 2026 executive order — Accelerating Medical Treatments for Serious Mental Illness — formally directed the FDA to expedite review of psychedelic therapies, instructed the DEA to remove administrative barriers to research and […]